Biopolym. Cell. 2018; 34(4):313-328.
http://dx.doi.org/10.7124/bc.000985
Bioorganic Chemistry
Increased antitumor efficiency and reduced negative side effects in laboratory mice of 4-thiazolidinone derivatives in complexes with PEG-containing polymeric nanocarrier
1Kobylinska L. I., 2Skorohyd N. R., 2Klyuchivska O. Yu., 3Mitina N. E., 3Zaichenko A. S., 1Lesyk R. B., 1Zimenkovsky B. S., 2Stoika R. S.
  1. Danylo Halytsky Lviv National Medical University
    69, Pekarska Str., Lviv, Ukraine, 79010
  2. Institute of Cell Biology, NAS of Ukraine
    14/16, Drahomanov Str., Lviv, Ukraine, 79005
  3. Lviv Polytechnic National University
    12, S. Bandery Str., Lviv, Ukraine, 79013

Abstract

Aim. To study an anticancer activity and to measure cytological and enzymatic indicators of general toxicity of 4-thiazolidinone-based compounds (Les-3288, Les-3833) in the NK/Ly lymphoma grafted to BALB/C mice. Methods. BALB/C mice were implanted with the ascitic NK/Ly lymphoma and treated for 14 days with 4-thiazolidinone derivatives – Les-3833 (2.5 mg/kg of bodyweight), Les-3288 (5 mg/kg of bodyweight), a complex of Les-3833 with the polymeric nanocarrier Les-3833+PNC (2.5 mg/kg of bodyweight) in water, and doxorubicin (1 mg/kg of bodyweight) used as a positive control. The lymphoma development was monitored by measuring the amount of ascitic fluid in the treated mice. The effects of the applied compounds were checked after 35 days of tumor growth. Results. A distinct decrease in the amount of the ascite fluid with lymphoma cells was revealed in the treated mice, while a 1.5-fold increase of its amount was detected in the untreated mice of control group. The 4-thiazolidinone derivatives demonstrated much less toxicity, and erythrocytes count stayed normal after 21 days of animal treatment. The development of NK/Ly lymphoma led to an increase in the neutrophils number, while the applied anticancer compounds reduced it significantly. Les-3833 and Les-3288 did not affect the number of lymphocytes over the normal level. The activity of aspartate and alanine aminotransferases in blood serum was elevated on the 14 day of treatment, and returned to the normal level on the 21 day. Conclusion. Novel 4-thiazolidinones Les-3833 and Les-3288 are effective in the treatment of NK/Ly lymphoma grafted to BALB/C mice. These derivatives induced had limited negative side effects in the treated mice.
Keywords: 4-thiazolidinones, murine lymphoma NK/Ly, BALB/C mice, glioma C6 cells, apoptosis
Full text: (PDF, in English)

References

[1] Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495-516.
[2] Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012;2012:195727.
[3] Narvekar M, Xue HY, Eoh JY, Wong HL. Nanocarrier for poorly water-soluble anticancer drugs--barriers of translation and solutions. AAPS PharmSciTech. 2014;15(4):822-33. Review.
[4] Feng R, Zhu W, Teng F, Liu N, Yang F, Meng N, Song Z. Poly(ethylene glycol) amphiphilic copolymer for anticancer drugs delivery. Anticancer Agents Med Chem. 2015;15(2):176-88.
[5] Khosroushahi AY, Naderi-Manesh H, Yeganeh H, Barar J, Omidi Y. Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities. J Nanobiotechnology. 2012;10:2.
[6] Zhang J, Li S, Li X. Polymeric nano-assemblies as emerging delivery carriers for therapeutic applications: a review of recent patents. Recent Pat Nanotechnol. 2009;3(3):225-31.
[7] Kim JY, Kim S, Pinal R, Park K. Hydrotropic polymer micelles as versatile vehicles for delivery of poorly water-soluble drugs. J Control Release. 2011;152(1):13-20.
[8] Bunker A. Poly(ethylene glycol) in drug delivery, why does it work, and can we do better? All atom molecular dynamics simulation provides some answers. Phys Procedia. 2012;34:24–33.
[9] Min Y, Caster JM, Eblan MJ, Wang AZ. Clinical Translation of Nanomedicine. Chem Rev. 2015;115(19):11147-90.
[10] Havrylyuk D, Zimenkovsky B, Vasylenko O, Gzella A, Lesyk R. Synthesis of new 4-thiazolidinone-, pyrazoline-, and isatin-based conjugates with promising antitumor activity. J Med Chem. 2012;55(20):8630-41.
[11] Riabtseva A, Mitina N, Boiko N, Garasevich S, Yanchuk I, Stoika R, Slobodyanyuk O, Zaichenko A. [Structural and colloidal-chemical characteristics of nanosized drug delivery systems based on pegylated comb-like carriers]. Chem Chem Technol. 2012;6(3):291–5.
[12] Riabtseva A, Mitina N, Grytsyna I, Boiko N, Garamus VM, Stryhanyuk H, Stoika R, Zaichenko A. Functional micelles formed by branched polymeric surfactants: Synthesis, characteristics, and application as nanoreactors and carriers. European Polymer Journal. 2016;75:406–22.
[13] Geran RS, Greenberg NH, Macdonald MM, Schumacher AM, Abbott BJ. Protocols for screening chemical agents and naturalproducts against animal tumors and other biological systems. Cancer Chemother Rep. 1972;3(2):1–87.
[14] Ronin VS, Utevsky NL. Textbook for classes on the methods of clinical laboratory investigations. 4th ed. Moscow: Medicine, 1989. 335 p.
[15] Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731-9.
[16] Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245(3):194-205.
[17] Chan YK, Tsai MH, Huang DC, Zheng ZH, Hung KD. Leukocyte nucleus segmentation and nucleus lobe counting. BMC Bioinformatics. 2010;11:558.
[18] Kobylinska L, Panchuk R, Skorohyd N, Senkiv Y, Heffeter P, Berger W, Boiko N, Mitina N, Zaichenko A, Lesyk R, Zimenkovsky B, Stoika R, Vari GS. Conjugation of anticancer drugs with novel PEG-containing nanocarrier provides circumvention of drug-resistance mechanisms in vitro and protects of general toxicity in vivo. Biotech, Biomaterials and Biomedical. Chapter 3: Materials for Drug & Gene Delivery. TechConnect Briefs. 2017;3:60–63.
[19] Kobylinska LI, Havrylyuk DY, Ryabtseva AO, Mitina NE, Zaichenko OS, Lesyk RB, Zimenkovsky BS, Stoika RS. Biochemical indicators of hepatotoxicity in blood serum of rats under the effect of novel 4-thiazolidinone derivatives and doxorubicin and their complexes with polyethyleneglycol-containing nanoscale polymeric carrier. Ukr Biochem J. 2015;87(2):122-32.
[20] Kobylinska LI, Havrylyuk DYa, Mitina NE, Zaichenko AS, Lesyk RB, Zimenkovsky BS, StoikaRS. Biochemical indicators of nephrotoxicity in blood serum of rats treated with novel 4-thiazolidinone derivatives or their complexes with polyethyleneglycol-containing nanoscale polymeric carrier. Ukr Biochem J. 2016;88(1):51–60.
[21] Biermann H, Pietz B, Dreier R, Schmid KW, Sorg C, Sunderkötter C. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol. 1999;65(2):217-31.
[22] Panchuk RR, Skorokhyd NR, Kozak YS, Lehka LV, Chumak VV, Omelyanchik SN, Gurinovich VA, Moiseenok AG, Stoika RS. Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice. Croat Med J. 2016;57(2):180-92.
[23] Kobylinska LI, Boiko NM, Panchuk RR, Grytsyna II, Klyuchivska OY, Biletska LP, Lesyk RB, Zimenkovsky BS, Stoika RS. Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats. Croat Med J. 2016;57(2):151-63.